Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
about
Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.GRAMD1B regulates cell migration in breast cancer cells through JAK/STAT and Akt signaling.Autophagy of macrophages is regulated by PI3k/Akt/mTOR signalling in the development of diabetic encephalopathyThe "Yin and Yang" of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
P2860
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
@en
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
@nl
type
label
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
@en
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
@nl
prefLabel
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
@en
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Vertical inhibition of the PI3K/Akt/mTOR pathway is synergistic in breast cancer.
@en
P2093
P2860
P2888
P356
10.1038/ONCSIS.2017.86
P50
P577
2017-10-09T00:00:00Z